Skip to main content

Page of 234
and
  1. No Access

    Article

    Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative splicing

    Due to insufficient knowledge about key molecular events, Hepatocellular carcinoma (HCC) lacks effective treatment targets. Spliceosome-related genes were significantly altered in HCC. Oncofetal proteins are i...

    Qipeng Wu, Ruyan Liao, Chunmeng Miao, Muhammad Hasnat, Le Li in British Journal of Cancer (2024)

  2. No Access

    Article

    Risk of anthracycline-induced cardiac dysfunction in adolescent and young adult (AYA) cancer survivors: role of genetic susceptibility loci

    There is a known genetic susceptibility to anthracycline-induced cardiac dysfunction in childhood cancer survivors, but this has not been adequately shown in adolescent and young adult (AYA) patients. Our aim ...

    Lily K. Stafford, **aohui Tang, Amanda Brandt, Jianzhong Ma in The Pharmacogenomics Journal (2024)

  3. Article

    Open Access

    Natural killer cell-derived exosome-based cancer therapy: from biological roles to clinical significance and implications

    Natural killer (NK) cells are important immune cells in the organism and are the third major type of lymphocytes besides T cells and B cells, which play an important function in cancer therapy. In addition to ...

    Chaohua Si, Jianen Gao, Xu Ma in Molecular Cancer (2024)

  4. Article

    Open Access

    Transcriptomics-based liquid biopsy panel for early non-invasive identification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer

    This study aimed to develop a novel six-gene expression biomarker panel to enhance the early detection and risk stratification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer (L...

    **’an Ding, Haotian Wu, Jiaxiang Wu in Journal of Experimental & Clinical Cancer … (2024)

  5. Article

    Open Access

    Clinical evaluation of an artificial intelligence-assisted cytological system among screening strategies for a cervical cancer high-risk population

    Primary cervical cancer screening and treating precancerous lesions are effective ways to prevent cervical cancer. However, the coverage rates of human papillomavirus (HPV) vaccines and routine screening are l...

    Wen Yang, **angshu **, Liying Huang, Shufang Jiang, Jia Xu, Yurong Fu in BMC Cancer (2024)

  6. Article

    Open Access

    Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis

    Lung cancer (LC), characterized by high incidence and mortality rates, presents a significant challenge in oncology. Despite advancements in treatments, early detection remains crucial for improving patient ou...

    **anzhe Fan, Ran Zhong, Hengrui Liang, Qiu Zhong, Hongtai Huang, Juan He in BMC Cancer (2024)

  7. Article

    Open Access

    Comparison of the diagnostic value of various microRNAs in blood for colorectal cancer: a systematic review and network meta-analysis

    Despite the existence of numerous studies investigating the diagnostic potential of blood microRNAs for colorectal cancer, the microRNAs under consideration vary widely, and comparative analysis of their diagn...

    Jianhao Xu, Lanfen Pan, Dan Wu, Liqian Yao, Wenqian Jiang, Jiarui Min in BMC Cancer (2024)

  8. Article

    Open Access

    Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits

    Jiaojiao Hao, Wenhua Fan, Yizhuo Li in Journal of Experimental & Clinical Cancer … (2024)

  9. Article

    Open Access

    Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2V617F-induced myeloproliferative neoplasms

    Mengshi Hu, Tao Yang, Linyu Yang, Lu Niu, **bing Zhu, Ailin Zhao in Blood Cancer Journal (2024)

  10. Article

    Open Access

    Quantitative parameter analysis of pretreatment dual-energy computed tomography in nasopharyngeal carcinoma cervical lymph node characteristics and prediction of radiotherapy sensitivity

    Treatment efficacy may differ among patients with nasopharyngeal carcinoma (NPC) at similar tumor–node–metastasis stages. Moreover, end-of-treatment tumor regression is a reliable indicator of treatment sensit...

    Zhiru Li, Chao Li, Liyan Li, Dong Yang, Shuangyue Wang, Junmei Song in Radiation Oncology (2024)

  11. Article

    Open Access

    IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma

    Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide. Inhibitor of kappa B kinase interacting protein (IKBIP) has been reported to promote glioma progression, but its role in o...

    Jiannan Hu, Chuan**g Dai, Zhaoji Ding, Yixiao Pan, Lingxiao Lu, Jiaqian Bao in BMC Cancer (2024)

  12. Article

    Open Access

    Acute kidney injury in cancer patients receiving anti-vascular endothelial growth factor monoclonal antibody vs. immune checkpoint inhibitors: a retrospective real-world study

    Anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF) or immune checkpoint inhibitors (ICIs) combined with chemotherapy are commonly administered to cancer patients. Although cancer patients ...

    Jianfen Zhu, **aokai Ding, Jianna Zhang, Bo Chen, **aohan You, **nxin Chen in BMC Cancer (2024)

  13. Article

    Open Access

    The safety and efficacy of volumetric modulated Arc therapy combined with computer tomography-guided adaptive brachytherapy for locally advanced cervical cancer: a single institution experience

    Volumetric modulated arc therapy (VMAT) is a novel form of IMRT, which can deliver more accurate dose distribution and shorten treatment time. Compared to MRI-guided adaptive brachytherapy, which is recommende...

    Tianyu Yang, Tiandi Zhao, Zhe Ji, Runhong Lei, Ang Qu, Weijuan jiang in Radiation Oncology (2024)

  14. Article

    Open Access

    QL1209 (pertuzumab biosimilar) versus reference pertuzumab plus trastuzumab and docetaxel in neoadjuvant treatment for HER2-positive, ER/PR-negative, early or locally advanced breast cancer: A multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trial

    This randomized, parallel-controlled, double-blinded, phase III equivalence study evaluated the equivalence of a proposed pertuzumab biosimilar QL1209 to the pertuzumab (Perjeta®) each with trastuzumab and doc...

    Wenjia Zuo, Zhonghua Wang, Jun Qian, **aopeng Ma, Zhaofeng Niu in British Journal of Cancer (2024)

  15. Article

    Open Access

    Genetically evaluating the causal role of peripheral immune cells in colorectal cancer: a two-sample Mendelian randomization study

    Investigating novel therapeutic strategies for colorectal cancer (CRC) is imperative. However, there is limited research on the use of drugs to target peripheral blood immune cells in this context. To address ...

    Runze Huang, **n **, Ziting Jiang, Yixiu Wang, Yibin Wu, Lu Wang in BMC Cancer (2024)

  16. Article

    Open Access

    The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer

    Though tamoxifen achieves success in treating estrogen receptor α (ERα)-positive breast cancer, the followed development of tamoxifen resistance is a common challenge in clinic. Signals downstream of prolactin...

    Jiawei Zhang, Junjun Liu, Yali Yue, Lei Wang in Journal of Experimental & Clinical Cancer … (2024)

  17. Article

    Open Access

    Correction: Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis

    Lei Deng, Hui Yang, Junwei Tang, Zhe Lin in Journal of Experimental & Clinical Cancer … (2024)

  18. Article

    Open Access

    Circ6834 suppresses non-small cell lung cancer progression by destabilizing ANHAK and regulating miR-873-5p/TXNIP axis

    Circular RNAs (circRNAs) play important roles in cancer progression and metastasis. However, the expression profiles and biological roles of circRNAs in non-small cell lung cancer (NSCLC) remain unclear.

    Maoye Wang, **aoge Ding, **njian Fang, **g Xu, Yanke Chen, Yu Qian in Molecular Cancer (2024)

  19. Article

    Open Access

    CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitors

    The combined use of CDK4/6 inhibitors and mTOR inhibitors has achieved some clinical success in ccRCC. Exploring the underlying mechanism of the CDK4/6 pathway in cancer cells and the drug interactions of CDK4...

    **nlin Liu, Wei Li, Lu Yi, Jianxi Wang, Wentao Liu in British Journal of Cancer (2024)

  20. Article

    Open Access

    Multi-omics profiling reveal cells with novel oncogenic cluster, TRAP1low/CAMSAP3low, emerge more aggressive behavior and poor-prognosis in early-stage endometrial cancer

    The clinical heterogeneity of early-stage endometrial cancer (EC) is worthy of further study to identify high-quality prognostic markers and their potential role in aggressive tumor behavior. Mutation of TP53 ...

    **aodan Mao, **aoyue Tang, **gxuan Ye, Shuxia Xu, Yue Wang in Molecular Cancer (2024)

Page of 234